Serum 25-hydroxyvitamin D and breast cancer risk by pathological subtype (MCC-Spain)
Autor(es) y otros:
Fecha de publicación:
2018
Versión del editor:
Citación:
Journal of Steroid Biochemistry and Molecular Biology, 182, p. 4-13 (2018); doi:10.1016/j.jsbmb.2018.04.005
Descripción física:
p. 4-13
ISSN:
Patrocinado por:
The study was funded by Carlos III Institute of Health grants (PI12/00488, PI12/00265, PI12/00715, PI12/01270, PI09/00773 and PI08/1770), by the Spanish Ministry of Health (EC11-273), by the SpanishMinistry of Economy and Competitiveness (IJCI-2014-20900) and byConsejería de Salud de la Junta de Andalucía (PI-0571-2009) compe-titive calls including peer review for scientific quality. Additionalfunding was provided by the Spanish Federation of Breast CancerPatients (FECMA: EPY 1169-10), the Association of Women with BreastCancer from Elche (AMACMEC: EPY 1394/15), the Marqués deValdecilla foundation (grant API 10/09), and by Acción Transversal delCancer, approved by the Spanish Ministry Council on October 11, 2007.
Colecciones
- Artículos [37532]
Ficheros en el ítem
Métricas
Compartir
